Inactive Instrument

curasan AG Stock price Xetra

Equities

DE0005494538

Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer - 20-12-31
Chief Tech/Sci/R&D Officer - -
Chief Operating Officer - -
Members of the board TitleAgeSince
Director/Board Member 58 19-09-15
Chairman - -
Director/Board Member - 18-12-31
More insiders
curasan AG is a Germany-based developer, producer and marketer of medical products in the areas of bone and tissue regeneration. The Company focuses on dentistry products and orthopedics. In the dentistry area, the Company focuses on bone regeneration and wound healing, offering CERASORB, Osbone, stypro and foils and membranes, as well as accessories, such as fixation systems. In the orthopedics area, the Company offers CERASORB, stypro and Curavisc for bone regeneration, wound healing and osteoarthritis therapy. The CERASORB product family provides bone replacement material for bone defects. stypro is a sterile and porous sponge from biomaterial that is implantable and resorbable. Osbone is a synthetic open-cell cancellous bone graft material for filling bone defects and for augmentation of the atrophied alveolar ridge.
Sector
-
More about the company
  1. Stock
  2. Equities
  3. Stock curasan AG
  4. Stock curasan AG - Xetra